It has been reported that hepatic steatosis and liver injury associated with steatohepatitis in mice can be alleviated by branched-chain amino acid diet supplementation, and by suppressing gene expression and the protein level of fatty acid synthase (FAS) [51]. Here, FASN is linked to fatty liver disease.